AI Insider Sales, Fresh Shorts, and a Big Earnings Beat

AI Insiders Cash Out

The clearest theme of the day is insider selling at AI-related names. NVDA director Mark Stevens filed $221M in sales last week. He sold 1 million shares at around $220 each. CRWV (CoreWeave) director Jack Cogen filed over $158M in sales since late May. Both men sold into strength. Short sellers agree with that caution. NVDA short interest hit $63B, up from 1.21% to 1.28% of free float in late May. CoreWeave shorts added 1.9 points week-on-week, pushing SI to 18.4%.

Earnings Kick Off With a Beat

CASY (Casey's General Stores) delivered a strong Q4 beat today. EPS came in at $4.37 against a $3.31 estimate. Sales hit $4.57B, topping the $4.30B forecast. ORCL reports tomorrow after the close, followed by ADBE and LEN on Wednesday. Across the Atlantic, BT.A releases full-year results Wednesday morning.

Short Sellers Make Fresh Moves

Bears piled into NNE (NANO Nuclear Energy), lifting SI by 3.7 points to 27.7% of free float. Availability is just 9.5% — shares to borrow are nearly gone. HOG (Harley-Davidson) attracted 2.5 points of new short interest, hitting 16.6% amid tariff and demand pressure. Analyst moves aligned: Keefe, Bruyette & Woods slapped a rare Sell on homebuilder LEN, cutting the target to $86.

Crypto and Biotech in Focus

One analyst flagged "avoid crypto for the summer," citing Bitcoin, Ethereum, and XRP. COIN carries 11.2% SI of free float. Biotech saw a lift: Cellectis secured FDA Regenerative Medicine Advanced Therapy designation for its CAR-T therapy candidate, a meaningful regulatory milestone. Jefferies raised its target on LLY to $1,350, keeping its Buy rating intact on the $1 trillion pharma giant.